Literature DB >> 7899135

Regulation of proteoglycan expression in fibrotic liver and cultured fat-storing cells.

A M Gressner1, N Krull, M G Bachem.   

Abstract

Considerable progress has been made in recent years with the molecular dissection of proteoglycans in normal and fibrotic human and rat liver. Proteoglycans constitute a major fraction of extracellular, pericellular and intracellular glycoconjugates. In former times, proteoglycans were classified nearly exclusively on the basis of the composition of their carbohydrate chain (glycosaminoglycan, GAG) attached to the core protein. Accordingly, three main types are discerned in liver, which are in order of decreasing concentrations heparan sulfate (HS, more than 60% of total GAG), dermatan sulfate and chondroitin-4,6-sulfate isomers. Keratan sulfate has not been detected in rat and human liver. Recently, proteoglycans have been characterized by sequencing and cloning of the core proteins to which a number of specific glycosaminoglycan side chains are covalently linked. Accordingly, decorin and biglycan have been identified as major chondroitin sulfate/dermatan sulfate proteoglycans in the extracellular space. In addition, evidence was obtained recently for the expression of aggrecan and lumican, both keratan sulfate bearing proteoglycans, and of syndecan in liver. Using in situ hybridization techniques the temporal and spatial pattern of expression of biglycan, decorin and aggrecan has been assessed. These studies together with Northern blot hybridizations performed with isolated parenchymal and nonparenchymal liver cells confirm that fat-storing cells (Ito cells, perisinusoidal lipocytes), are the most important, principal cellular site of proteoglycan production in diseased liver. The level of expression is regulated by a number of cytokines among which TGF beta, TNF alpha and TGF alpha play significant roles. The effects of these cytokines on proteoglycan expression are dependent on the stage of phenotypic transition of fat storing cells to the activated myofibroblast. Taken together, these data point to the potentially significant role which proteoglycans might fulfil in the regulation of cellular functions and in the maintenance of the supramolecular organization of the extracellular matrix in normal and in diseased liver during the process of fibrogenesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7899135     DOI: 10.1016/S0344-0338(11)80990-8

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  13 in total

Review 1.  Proteoglycans in liver cancer.

Authors:  Kornélia Baghy; Péter Tátrai; Eszter Regős; Ilona Kovalszky
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

2.  Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update.

Authors:  Gamal Shiha; Alaa Ibrahim; Ahmed Helmy; Shiv Kumar Sarin; Masao Omata; Ashish Kumar; David Bernstien; Hitushi Maruyama; Vivek Saraswat; Yogesh Chawla; Saeed Hamid; Zaigham Abbas; Pierre Bedossa; Puja Sakhuja; Mamun Elmahatab; Seng Gee Lim; Laurentius Lesmana; Jose Sollano; Ji-Dong Jia; Bahaa Abbas; Ashraf Omar; Barjesh Sharma; Diana Payawal; Ahmed Abdallah; Abdelhamid Serwah; Abdelkhalek Hamed; Aly Elsayed; Amany AbdelMaqsod; Tarek Hassanein; Ahmed Ihab; Hamsik GHaziuan; Nizar Zein; Manoj Kumar
Journal:  Hepatol Int       Date:  2016-10-06       Impact factor: 6.047

3.  Increased expression of chondroitin sulphate proteoglycans in rat hepatocellular carcinoma tissues.

Authors:  Xiao-Li Jia; Si-Yuan Li; Shuang-Suo Dang; Yan-An Cheng; Xin Zhang; Wen-Jun Wang; Clare E Hughes; Bruce Caterson
Journal:  World J Gastroenterol       Date:  2012-08-14       Impact factor: 5.742

Review 4.  Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next Step.

Authors:  Ralf Weiskirchen
Journal:  Front Pharmacol       Date:  2016-01-07       Impact factor: 5.810

5.  Gene expression patterns in human liver cancers.

Authors:  Xin Chen; Siu Tim Cheung; Samuel So; Sheung Tat Fan; Christopher Barry; John Higgins; Kin-Man Lai; Jiafu Ji; Sandrine Dudoit; Irene O L Ng; Matt Van De Rijn; David Botstein; Patrick O Brown
Journal:  Mol Biol Cell       Date:  2002-06       Impact factor: 4.138

6.  Association of differentially expressed genes with activation of mouse hepatic stellate cells by high-density cDNA microarray.

Authors:  Xiao-Jing Liu; Li Yang; Feng-Ming Luo; Hong-Bin Wu; Qu Qiang
Journal:  World J Gastroenterol       Date:  2004-06-01       Impact factor: 5.742

Review 7.  Elastin in the Liver.

Authors:  Jiří Kanta
Journal:  Front Physiol       Date:  2016-10-25       Impact factor: 4.566

8.  Lumican binds ALK5 to promote epithelium wound healing.

Authors:  Osamu Yamanaka; Yong Yuan; Vivien Jane Coulson-Thomas; Tarsis Ferreira Gesteira; Mindy K Call; Yujin Zhang; Jianhua Zhang; Shao-Hsuan Chang; Changchun Xie; Chia-Yang Liu; Shizuya Saika; James V Jester; Winston W-Y Kao
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240

9.  Activation of TGF-beta within cultured hepatocytes and in liver injury leads to intracrine signaling with expression of connective tissue growth factor.

Authors:  Olav A Gressner; Birgit Lahme; Monika Siluschek; Katharina Rehbein; Jens Herrmann; Ralf Weiskirchen; Axel M Gressner
Journal:  J Cell Mol Med       Date:  2008-02-04       Impact factor: 5.310

10.  Differential effects of hyaluronan synthase 3 deficiency after acute vs chronic liver injury in mice.

Authors:  Jennifer M McCracken; Lu Jiang; Krutika T Deshpande; Maura F O'Neil; Michele T Pritchard
Journal:  Fibrogenesis Tissue Repair       Date:  2016-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.